1. Home
  2. PNBK vs VIRX Comparison

PNBK vs VIRX Comparison

Compare PNBK & VIRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PNBK
  • VIRX
  • Stock Information
  • Founded
  • PNBK 1999
  • VIRX 2007
  • Country
  • PNBK United States
  • VIRX United States
  • Employees
  • PNBK N/A
  • VIRX N/A
  • Industry
  • PNBK Major Banks
  • VIRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PNBK Finance
  • VIRX Health Care
  • Exchange
  • PNBK Nasdaq
  • VIRX Nasdaq
  • Market Cap
  • PNBK 7.3M
  • VIRX 7.7M
  • IPO Year
  • PNBK N/A
  • VIRX N/A
  • Fundamental
  • Price
  • PNBK $1.81
  • VIRX $0.15
  • Analyst Decision
  • PNBK
  • VIRX Buy
  • Analyst Count
  • PNBK 0
  • VIRX 4
  • Target Price
  • PNBK N/A
  • VIRX $5.00
  • AVG Volume (30 Days)
  • PNBK 117.3K
  • VIRX 2.7M
  • Earning Date
  • PNBK 11-22-2024
  • VIRX 11-13-2024
  • Dividend Yield
  • PNBK N/A
  • VIRX N/A
  • EPS Growth
  • PNBK N/A
  • VIRX N/A
  • EPS
  • PNBK N/A
  • VIRX N/A
  • Revenue
  • PNBK $24,218,000.00
  • VIRX N/A
  • Revenue This Year
  • PNBK N/A
  • VIRX N/A
  • Revenue Next Year
  • PNBK N/A
  • VIRX N/A
  • P/E Ratio
  • PNBK N/A
  • VIRX N/A
  • Revenue Growth
  • PNBK N/A
  • VIRX N/A
  • 52 Week Low
  • PNBK $1.39
  • VIRX $0.13
  • 52 Week High
  • PNBK $5.50
  • VIRX $1.31
  • Technical
  • Relative Strength Index (RSI)
  • PNBK 52.93
  • VIRX 22.07
  • Support Level
  • PNBK $1.72
  • VIRX $0.17
  • Resistance Level
  • PNBK $2.05
  • VIRX $0.21
  • Average True Range (ATR)
  • PNBK 0.13
  • VIRX 0.02
  • MACD
  • PNBK 0.02
  • VIRX -0.00
  • Stochastic Oscillator
  • PNBK 55.56
  • VIRX 19.80

About PNBK Patriot National Bancorp Inc.

Patriot National Bancorp Inc provides consumer and commercial banking services to individuals, small and medium-sized businesses, professionals, and municipalities in Fairfield and New Haven Counties in Connecticut and Westchester County, New York. Its products include checking accounts, savings accounts, money market accounts, time certificates of deposit, and individual retirement accounts. The Bank's lending portfolio is comprised of commercial mortgage and construction loans, commercial loans, home improvement loans, home equity lines of credit, and other personal loans. In addition, the Bank offers bank checks, money orders, automated teller machines, interactive teller machines, online and mobile banking, credit cards, and debit cards.

About VIRX Viracta Therapeutics Inc.

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.

Share on Social Networks: